Procter & Gamble (NYSE:PG) PT Raised to $176.00 at Deutsche Bank Aktiengesellschaft

Procter & Gamble (NYSE:PG) had its price target upped by Deutsche Bank Aktiengesellschaft from $171.00 to $176.00 in a research note issued to investors on Wednesday, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

A number of other research firms also recently weighed in on PG. Jefferies Financial Group lifted their target price on Procter & Gamble from $175.00 to $182.00 and gave the stock a buy rating in a report on Monday, April 22nd. Barclays lifted their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an overweight rating in a research note on Tuesday, April 23rd. StockNews.com lowered shares of Procter & Gamble from a buy rating to a hold rating in a research report on Tuesday, July 16th. Argus lifted their price target on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a buy rating in a research report on Thursday, April 25th. Finally, Citigroup increased their price target on Procter & Gamble from $177.00 to $190.00 and gave the stock a buy rating in a research report on Wednesday, July 10th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company has an average rating of Moderate Buy and an average price target of $172.75.

Procter & Gamble Stock Up 0.3 %

Procter & Gamble stock opened at $167.96 on Wednesday. The company’s 50-day moving average price is $166.30 and its two-hundred day moving average price is $160.91. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The stock has a market cap of $396.41 billion, a P/E ratio of 27.44, a P/E/G ratio of 3.16 and a beta of 0.41. Procter & Gamble has a twelve month low of $141.45 and a twelve month high of $170.92.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. During the same quarter last year, the company earned $1.37 earnings per share. The firm’s quarterly revenue was up .6% compared to the same quarter last year. As a group, analysts expect that Procter & Gamble will post 6.55 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a $1.0065 dividend. The ex-dividend date is Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a yield of 2.40%. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Insider Transactions at Procter & Gamble

In related news, CEO R. Alexandra Keith sold 855 shares of the business’s stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the sale, the chief executive officer now owns 4,004 shares in the company, valued at approximately $634,634. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Balaji Purushothaman sold 28,369 shares of Procter & Gamble stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares in the company, valued at $1,858,265.43. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 855 shares of the stock in a transaction on Monday, April 22nd. The shares were sold at an average price of $158.50, for a total value of $135,517.50. Following the completion of the sale, the chief executive officer now owns 4,004 shares of the company’s stock, valued at $634,634. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 154,544 shares of company stock worth $25,413,051. Corporate insiders own 0.17% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Norges Bank bought a new stake in Procter & Gamble in the fourth quarter valued at approximately $3,956,117,000. Cerity Partners LLC increased its position in shares of Procter & Gamble by 106.2% during the fourth quarter. Cerity Partners LLC now owns 6,134,455 shares of the company’s stock worth $898,943,000 after buying an additional 3,159,796 shares during the period. International Assets Investment Management LLC raised its stake in Procter & Gamble by 13,850.3% during the fourth quarter. International Assets Investment Management LLC now owns 2,747,379 shares of the company’s stock worth $402,601,000 after buying an additional 2,727,685 shares during the last quarter. Assenagon Asset Management S.A. lifted its holdings in Procter & Gamble by 235.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 3,231,032 shares of the company’s stock valued at $473,475,000 after buying an additional 2,268,805 shares during the period. Finally, TD Asset Management Inc boosted its position in Procter & Gamble by 114.9% during the first quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after acquiring an additional 1,907,716 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.